Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Bio-Techne Corp
NASDAQ:TECH

Watchlist Manager
Bio-Techne Corp Logo
Bio-Techne Corp
NASDAQ:TECH
Watchlist
Price: 67.11 USD 1.9% Market Closed
Market Cap: $10.5B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

TECH Price Targets Summary
Bio-Techne Corp

Wall Street analysts forecast TECH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TECH is 71.44 USD with a low forecast of 60.6 USD and a high forecast of 78.75 USD.

TECH Lowest Forecast
Wall Street Target
60.6 USD
-10% Downside
TECH Average Forecast
Wall Street Target
71.44 USD
6% Upside
TECH Highest Forecast
Wall Street Target
78.75 USD
17% Upside
Lowest
Price Target
60.6 USD
10% Downside
Average
Price Target
71.44 USD
6% Upside
Highest
Price Target
78.75 USD
17% Upside
Bio-Techne Corp Competitors:
Price Targets
SCM
Solutions Capital Management SIM SpA
42% Upside
D
DREAMFOLKS
Dreamfolks Services Ltd
57% Upside
BARK
Bark Inc
180% Upside
SCM
Solutions Capital Management SIM SpA
42% Upside
D
DREAMFOLKS
Dreamfolks Services Ltd
57% Upside
BARK
Bark Inc
180% Upside

Revenue
Forecast

11% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
11% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Bio-Techne Corp's revenue is 11%. The projected CAGR for the next 3 years is 6%.

What are analyst estimates?

Operating Income
Forecast

3% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss
3% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss

For the last 13 years the compound annual growth rate for Bio-Techne Corp's operating income is 3%. The projected CAGR for the next 3 years is 24%.

What are analyst estimates?

Net Income
Forecast

-3% / Year
Past Growth
77% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
-3% / Year
Past Growth
77% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

For the last 13 years the compound annual growth rate for Bio-Techne Corp's net income is -3%. The projected CAGR for the next 3 years is 77%.

What are analyst estimates?

See Also

Summary
TECH intrinsic value, competitors valuation, and company profile.
DCF Valuation
TECH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TECH stock valuation using valuation multiples.
Wall Street Estimates
TECH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TECH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TECH's stock price target?
Price Target
71.44 USD

According to Wall Street analysts, the average 1-year price target for TECH is 71.44 USD with a low forecast of 60.6 USD and a high forecast of 78.75 USD.

What is Bio-Techne Corp's Revenue forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Bio-Techne Corp's revenue is 11%. The projected CAGR for the next 3 years is 6%.

What is Bio-Techne Corp's Operating Income forecast?
Projected CAGR
24%

For the last 13 years the compound annual growth rate for Bio-Techne Corp's operating income is 3%. The projected CAGR for the next 3 years is 24%.

What is Bio-Techne Corp's Net Income forecast?
Projected CAGR
77%

For the last 13 years the compound annual growth rate for Bio-Techne Corp's net income is -3%. The projected CAGR for the next 3 years is 77%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.